glutathione small cell lung cancer Decreased biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small Squamous cell lung cancer: Current
Squamous cell lung cancer: Current landscape and future therapeutic options: Cancer Cell Metabolic reprogramming in non small cell lung cancer: unraveling therapeutic vulnerabilities and resistance mechanisms Journal of Rare Diseases Springer Nature Link The crosstalk between glutathione metabolism and non coding RNAs in cancer progression and treatment resistance ScienceDirect The Rockefeller University Mitochondrial antioxidant found to drive breast cancer metastasis
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



